Citation Impact
Citing Papers
Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature
2010
Corticotroph Tumor Progression after Adrenalectomy in Cushing’s Disease: A Reappraisal of Nelson’s Syndrome
2006
A Combined Dexamethasone Desmopressin Test as an Early Marker of Postsurgical Recurrence in Cushing’s Disease
2009
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing's syndrome?
2011
Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years
2012
Acromegaly
2006 Standout
Platelet Drop and Fibrinolytic Shutdown in Patients With Sepsis
2017
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: A prospective, long-term study
2005
Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery
2011
Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy.
1995
Long-Term Impaired Quality of Life in Cushing’s Syndrome despite Initial Improvement after Surgical Remission
2006
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Impaired Desensitization of a Mutant Adrenocorticotropin Receptor Associated with Apparent Constitutive Activity
2002
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
2012
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells
2001
Small cerebellar cortex volume in patients with active Cushing's syndrome
2014
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
2003
Individualized markers optimize class prediction of microarray data
2006
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
1999 Standout
Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol
2012
Autophagy and the Integrated Stress Response
2010 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Merits and pitfalls of mifepristone in Cushing's syndrome
2009
Stereotactic radiosurgery for Cushing disease: a review
2007
Influence of the Fibroblast Growth Factor Receptor 4 Expression and the G388R Functional Polymorphism on Cushing’s Disease Outcome
2010
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Mortality in Cushing's syndrome: A systematic review and meta-analysis
2011
Long-Term Predictive Value of Postsurgical Cortisol Concentrations for Cure and Risk of Recurrence in Cushing’s Disease
2003
Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans
2010
Elevated late‐night salivary cortisol levels in elderly male type 2 diabetic veterans
2005
Role of Brg1 and HDAC2 in GR trans -repression of the pituitary POMC gene and misexpression in Cushing disease
2006
Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results
2004
Cushing's syndrome
2015 Standout
Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study
2004
Phaeochromocytoma
2005 Standout
Cabergoline monotherapy in the long-term treatment of Cushing's disease
2010
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study
2011
Medical Treatment of Cushing's Disease
2013
Pharmacologic Management of Cushing Syndrome
2005
Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances
2007
Recurrence of Cushing's Disease Preceded by the Reappearance of ACTH and Cortisol Responses to Desmopressin Test
2004
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
1995 StandoutNature
Endocrine and Non-Endocrine Activities of Growth Hormone Secretagogues in Humans
1999
Midnight Salivary Cortisol for the Initial Diagnosis of Cushing’s Syndrome of Various Causes
2004
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
1998 Standout
Clinical and Genetic Heterogeneity, Overlap with Other Tumor Syndromes, and Atypical Glucocorticoid Hormone Secretion in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Compared with Other Adrenocortical Tumors
2009
Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride
2000
Cyclic Cushing’s syndrome: a clinical challenge
2007
Pros and cons of screening for occult Cushing syndrome
2011
Reproducibility of Nighttime Salivary Cortisol and Its Use in the Diagnosis of Hypercortisolism Compared with Urinary Free Cortisol and Overnight Dexamethasone Suppression Test
2005
DNA methylation in metabolic disorders
2011
The biology of VEGF and its receptors
2003 Standout
Subclinical Cushing's Syndrome
2004
Age-associated Cardiovascular Changes in Health: Impact on Cardiovascular Disease in Older Persons
2002
Pheochromocytoma in Italy: a multicentric retrospective study
1999
VEGF receptor signalling ? in control of vascular function
2006 Standout
Leuprolide Acetate Therapy in Luteinizing Hormone–Dependent Cushing's Syndrome
1999
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
1993 Standout
AMPK, insulin resistance, and the metabolic syndrome
2013
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire
2008
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
2005
Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome
2007
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
2014
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
Cushing’s Syndrome during Pregnancy: Personal Experience and Review of the Literature
2005
cAMP/PKA signaling defects in tumors: Genetics and tissue-specific pluripotential cell-derived lesions in human and mouse
2013
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Aberrant Expression of Hormone Receptors in Adrenal Cushing's Syndrome
2004
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Type 2 diabetes
2017 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Diagnosis and treatment of pediatric Cushing’s disease
2007
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
2012 Standout
Assessment of Left Ventricular Diastolic Function and Tei Index by Tissue Doppler Imaging in Patients with Cushing's Syndrome
2007
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase
2013
Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas
2014
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome
2007
Cyclical Cushing's syndrome: an update
2007
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
1995 StandoutNature
Laparoscopic adrenalectomy: 100 resections with clinical long-term follow-up
2004
Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease
2004
Cushing’s syndrome in a clinic population with diabetes
2007
ACTH-independent macronodular adrenal hyperplasia
2009
Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth
2008
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Gene Is a Sufficient Genetic Event to Induce Benign Adrenocortical Tumor in a Xenotransplantation Model
2005
The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing’s Syndrome
2004
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
Retinoic Acid as a Novel Medical Therapy for Cushing’s Disease in Dogs
2006
Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 Patients
2001
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
1996 StandoutNature
Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls
2008
Cushing's syndrome
2006 Standout
Atherosclerosis
2000 StandoutNature
Long-term follow-up results of postoperative radiation therapy for Cushing’s disease
2007
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region
2013
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing’s syndrome
2014
Ghrelin: Structure and Function
2005 Standout
Metformin—mode of action and clinical implications for diabetes and cancer
2014
Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome
2005
Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction
2009
Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas
2005
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing?s syndrome
2004
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
1997 StandoutScience
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Surgical Remission of Pituitary Adenomas Confined to the Neurohypophysis in Cushing’s Disease
2006
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
1997 StandoutScience
Cooperation between Cyclin E and p27Kip1 in Pituitary Tumorigenesis
2010
Depressive State and Paresthesia Dramatically Improved by Intravenous MgSO4 in Gitelman's Syndrome
2004
Magnesium in Man: Implications for Health and Disease
2014 Standout
CLINICAL REVIEW: The Strategy of Immediate Reoperation for Transsphenoidal Surgery for Cushing’s Disease
2005
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
1997 StandoutScience
Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
2003
Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients
2005
AMPK and SIRT1: a long-standing partnership?
2010
Síndrome de cushing endógena: características clínico-laboratoriais em 73 casos
2007
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
1994
Novel Fat Depot–Specific Mechanisms Underlie Resistance to Visceral Obesity and Inflammation in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice
2011
Occult Cushing’s Syndrome in Type-2 Diabetes
2003
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Differential Diagnosis and Imaging in Cushing's Syndrome
2005
The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.
1993
Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome
2007
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
2013
Pheochromocytoma
2002
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008
Impaired decision‐making and selective cortical frontal thinning in Cushing's syndrome
2014
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
2013
Thyroid Hormone Regulation of Metabolism
2014 Standout
Gamma Knife surgery for Cushing's disease
2007
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Increased Prevalence of Radiological Spinal Deformities in Active Acromegaly: A Cross-Sectional Study in Postmenopausal Women
2005
The Role of Laparoscopic Surgery in Adrenal Disease
1998
Pitfalls in the diagnosis of Cushing's syndrome
2007
Diagnostic Tests for Children Who Are Referred for the Investigation of Cushing Syndrome
2007
Cushing’s Syndrome: Important Issues in Diagnosis and Management
2006
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Food-Dependent Cushing’s Syndrome: Possible Involvement of Leptin in Cortisol Hypersecretion*
1999
Pathophysiology of adrenal hypertension
2002
Are Ectopic or Abnormal Membrane Hormone Receptors Frequently Present in Adrenal Cushing’s Syndrome?1
2000
Subclinical Hypercortisolism among Outpatients Referred for Osteoporosis
2007
The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies
2000
Phaeochromocytoma with Normal Urinary Catecholamines: The Potential Value of Urinary Free Metadrenalines
2002
Aberrant Membrane Hormone Receptors in Incidentally Discovered Bilateral Macronodular Adrenal Hyperplasia with Subclinical Cushing’s Syndrome
2001
Adrenocortical Carcinoma
2013
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study
2013
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
ARMC5Mutations Are Common in Familial Bilateral Macronodular Adrenal Hyperplasia
2014
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
2001
A review of feature selection techniques in bioinformatics
2007 Standout
The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment
2005
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Endothelial-specific gene expression directed by the tie gene promoter in vivo
1995
Works of Giorgio Arnaldi being referenced
AME Position Statement on adrenal incidentaloma
2011
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines
2004
Apparent mineralocorticoid excess type II
1994
Vasopressin receptors modulate the pharmacological phenotypes of cushing's syndrome
1998
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications
2012
Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation
2007
Expression of the Novel Adrenocorticotropin-Responsive Gene Selective Alzheimer’s Disease Indicator-1 in the Normal Adrenal Cortex and in Adrenocortical Adenomas and Carcinomas
2004
Variable Expression of the V1 Vasopressin Receptor Modulates the Phenotypic Response of Steroid-Secreting Adrenocortical Tumors1
1998
Adrenocorticotropin and Cortisol Hyperresponsiveness to Hexarelin in Patients with Cushing’s Disease Bearing a Pituitary Microadenoma, But Not in Those with Macroadenoma1
1998
Telomerase Activity Is Significantly Enhanced in Malignant Adrenocortical Tumors in Comparison to Benign Adrenocortical Adenomas
2000
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
2000
Coagulopathy in Cushing’s Syndrome
2010
A Survey on Adrenal Incidentaloma in Italy1
2000
Cardiovascular Risk In Cushing's Syndrome
2004
Adrenal Incidentaloma: An Overview of Hormonal Data from the National Italian Study Group
1997
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation
2010
Transforming Growth Factor β1: Implications in Adrenocortical Tumorigenesis
2000
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia
2010
Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status
2003
Laparoscopic adrenalectomy: a report on 50 operations
1998
Acth receptor mRNA in human adrenocortical tumors: Overexpression in aldosteronomas
1998
Severe hypomagnesaemia‐induced hypocalcaemia in a patient with Gitelman’s syndrome
2002
Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma
2002
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA
1992
Body Composition and Metabolic Features in Women with Adrenal Incidentaloma or Cushing’s Syndrome
2001
Self Image and Quality of Life in Acromegaly
2002
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: Evaluation by a simplified quantitative PCR assay
1994
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study
2014
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors
2016
Approach to the Patient with Possible Cushing’s Syndrome
2009
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation.
2012
Targeting Estrogen Receptor-α Reduces Adrenocortical Cancer (ACC) Cell Growthin Vitroandin Vivo: Potential Therapeutic Role of Selective Estrogen Receptor Modulators (SERMs) for ACC Treatment
2012
Cyclical Cushing’s Syndrome in a Patient with a Bronchial Neuroendocrine Tumor (Typical Carcinoid) Expressing Ghrelin and Growth Hormone Secretagogue Receptors
2003
Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome
2008
Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart.
1991
Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart.
1991
Variable Expression of the V1 Vasopressin Receptor Modulates the Phenotypic Response of Steroid-Secreting Adrenocortical Tumors
1998
Angiotensin II Receptors in Cortical and Medullary Adrenal Tumors1
1997
AMP‐activated protein kinase mediates glucocorticoid‐ induced metabolic changes: a novel mechanism in Cushing's syndrome
2008
Variable Expression of the Transcription Factors cAMP Response Element-Binding Protein and Inducible cAMP Early Repressor in the Normal Adrenal Cortex and in Adrenocortical Adenomas and Carcinomas
2001